Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/27/17 → 1/23/19 |
16-HEM-07-PP (13-601) A Phase 1/2A Open-Label, Multi-Dose, Multi-Center Escalation and Exploratory Study of Cerdulatinib (PRT062070) in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma
- Saeed, Hayder (PI)
- Zia, Maryam (Former PI)